Benzacot en es it fr

Benzacot Brand names, Benzacot Analogs

Benzacot Brand Names Mixture

  • Alphasel tablets (calcium phosphate [dibasic] + cobalt sulfate + D-alpha tocopheryl acetate + selenium sulfide)
  • Previte (neomycin sulfate + selenium sulfide + streptomycin sulfate + vitamin A + vitamin D + vitamin E + vitamin K1)

Benzacot Chemical_Formula


Benzacot RX_link

No information avaliable

Benzacot fda sheet

Benzacot msds (material safety sheet)

Benzacot MSDS

Benzacot Synthesis Reference

No information avaliable

Benzacot Molecular Weight

280.285 g/mol

Benzacot Melting Point

No information avaliable

Benzacot H2O Solubility

No information avaliable

Benzacot State


Benzacot LogP


Benzacot Dosage Forms

Intravenous (loading dose of 12 to 24 micrograms/kg over 10 minutes followed by a continuous infusion of 0.05 to 0.2 micrograms/kg per minute, adjusted according to response)

Benzacot Indication

For short term treatment of acutely decompensated severe chronic heart failure (CHF).

Benzacot Pharmacology

Levosimendan is a new Ca2+-sensitizing inotropic agent. Ca2+ sensitizers represent a new class of inotropic agents, which overcome the disadvantages associated with currently available inotropic agents in as they are not associated with an increased risk of arrhythmias, cell injury and death due to Ca2+ overload in myocardial cells; they do not increase the activation energy; and they have the potential to reverse contractile dysfunction under pathophysiologic conditions, such as acidosis or myocardial stunning. Levosimendan has not been approved for use in the U.S. or Canada.

Benzacot Absorption

The bioavailability of oral levosimendan is 85 ± 6% in healthy volunteers and 84 ± 4% in patients.

Benzacot side effects and Toxicity

No information avaliable

Benzacot Patient Information

No information avaliable

Benzacot Organisms Affected

Humans and other mammals